YMAB - Wall Street Estimates - Y-mAbs Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 6.16

-0.324 %

$ 276 M

Market Cap

-11.41

P/E

Price Target Average

277.44%

Revenue Forecast Estimate

14.44%

EBIT Estimate

--31.63%

Net Income Estimate

--29.45%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Y-mAbs Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for YMAB of $23.2 , with forecasts ranging from a low of $21 to a high of $26 .

YMAB Lowest Price Target Wall Street Target

21 USD 240.91%

YMAB Average Price Target Wall Street Target

23.2 USD 277.44%

YMAB Highest Price Target Wall Street Target

26 USD 322.08%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free